LONDON, August 9, 2018 /PRNewswire/ -- Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that impacts an individual ability to focus, self-control and perform other skills important in daily life.Download the full report: https://www.reportbuyer.com/product/5483273
ADHD is caused due to biochemical, connectivity and the structural difference in the mind. Symptoms of the Attention Deficit Hyperactivity Disorder (ADHD) mostly advances over a period of time and varies according to the type of causing factor and according to the age group of the person. The common symptoms in patient population are trouble at work, low self-esteem and substance abuse or addiction, low-stress tolerance level, mood swings and many more. Further, on the basis of symptoms, ADHD is classified into three key categories including the predominantly inattentive, predominantly hyperactive-impulsive and combined type. ADHD is diagnosed using a comprehensive evaluation of the patient mental and behavior condition. Various treatment options are pharmacological treatment, educational interventions & other behavioral therapies and EEG biofeedback therapies, physicians could reduce the disorder symptoms and its effects on the individual health.The U.S. emerged as a major region for the ADHD market due to increased healthcare expenditure incurred on the treatment & diagnosis of the ADHD patients and growth in the number of hospitals & clinics offering EEG biofeedback & dual therapy.The global attention deficit hyperactivity disorder (ADHD) market is expected to grow with increasing pharmaceutical R&D spending, growing healthcare expenditure, accelerating economic growth, unmet treatment needs and mounting occurrence of ADHD. Key trends and developments of this market includes progressing drugs under pipeline, high demand for dual therapy and rising preference for EEG biofeedback therapy. However, there are some factors which can hinder growth of the market including Medical complications of existing drug therapies, high domination of generic pharmaceutical market and strict government protocols.The report "Global Attention Deficit Hyperactivity Disorder (ADHD) Market: Industry Analysis & Outlook (2018-2022)" by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers, key tends & developments and challenges of the market, covering the U.S., Europe along with the global market. The report profiles the key players of the market including Shire Plc, Johnson and Johnson, Eli Lilly and Company and Novartis International AG.Download the full report: https://www.reportbuyer.com/product/5483273
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: [email protected]
Tel: +1 (718) 213 4904 Website: www.reportbuyer.com
Advertisement
View original content:http://www.prnewswire.com/news-releases/global-attention-deficit-hyperactivity-disorder-adhd-market-industry-analysis--outlook-2018-2022-300694867.html
SOURCE ReportBuyer
